These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. McKenna MC; Hubbard VS; Bieri JG J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):45-51. PubMed ID: 3981368 [TBL] [Abstract][Full Text] [Related]
25. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Olmedilla B; Granado F; Southon S; Wright AJ; Blanco I; Gil-Martinez E; van den Berg H; Thurnham D; Corridan B; Chopra M; Hininger I Clin Sci (Lond); 2002 Apr; 102(4):447-56. PubMed ID: 11914107 [TBL] [Abstract][Full Text] [Related]
26. Effects of creatine supplementation in cystic fibrosis: results of a pilot study. Braegger CP; Schlattner U; Wallimann T; Utiger A; Frank F; Schaefer B; Heizmann CW; Sennhauser FH J Cyst Fibros; 2003 Dec; 2(4):177-82. PubMed ID: 15463870 [TBL] [Abstract][Full Text] [Related]
27. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study. O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040 [TBL] [Abstract][Full Text] [Related]
28. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K; Weren M; Proesmans M; Kerem E Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [TBL] [Abstract][Full Text] [Related]
29. Antioxidant micronutrients for lung disease in cystic fibrosis. Shamseer L; Adams D; Brown N; Johnson JA; Vohra S Cochrane Database Syst Rev; 2010 Dec; (12):CD007020. PubMed ID: 21154377 [TBL] [Abstract][Full Text] [Related]
30. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Weiss B; Bujanover Y; Yahav Y; Vilozni D; Fireman E; Efrati O Pediatr Pulmonol; 2010 Jun; 45(6):536-40. PubMed ID: 20503277 [TBL] [Abstract][Full Text] [Related]
31. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. Schmitt-Grohé S; Zielen S Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Kim JS; Okamoto K; Rubin BK Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004 [TBL] [Abstract][Full Text] [Related]
33. The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. Farrell PM; Bieri JG; Fratantoni JF; Wood RE; di Sant'Agnese PA J Clin Invest; 1977 Jul; 60(1):233-41. PubMed ID: 874086 [TBL] [Abstract][Full Text] [Related]
34. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205 [TBL] [Abstract][Full Text] [Related]
35. Choline Supplementation in Cystic Fibrosis-The Metabolic and Clinical Impact. Bernhard W; Lange R; Graepler-Mainka U; Engel C; Machann J; Hund V; Shunova A; Hector A; Riethmüller J Nutrients; 2019 Mar; 11(3):. PubMed ID: 30889905 [TBL] [Abstract][Full Text] [Related]
36. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Wood LG; Fitzgerald DA; Lee AK; Garg ML Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335 [TBL] [Abstract][Full Text] [Related]
37. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Sagel SD; Kapsner R; Osberg I; Sontag MK; Accurso FJ Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1425-31. PubMed ID: 11704590 [TBL] [Abstract][Full Text] [Related]
38. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]
40. Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis. Lai HJ; Chin LH; Murali S; Bach T; Sander D; Farrell PM; Pediatr Pulmonol; 2022 Apr; 57(4):935-944. PubMed ID: 35018747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]